Akouos is a biotechnology company focused on restoring and preserving hearing. Akouos’s scientific founders are world leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy
Founder & CEO: Dr. Manny Simons
2 articles with Akouos
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.
Akouos, based in Boston, announced a Series A financing worth $50 million. The round was led by seed investors 5AM Ventures and New Enterprise Associates (NEA).